News About: Pharm. Industry
Dongwha opens new R&D center
Dongwha Pharm Chairman Yoon Do-joon called on his company to secure original core technology on May 26.
The move comes at a time when Dongwha is making all-out to go global.
"Securing core technology is top prio...
Large drugmakers to be hit by double punishment
Korea’s large drug makers are struggling to cope with sluggish sales of their flagship products as external environments are harsh and gloomy.
These days, pharmaceutical companies face the government’s intensive ca...
Leading pharmaceutical firms beleaguered by two-way sanction
Local leading companies are faced with a burden of weakening growth potential, falling profitability and worsening financial soundness in the wake of doctors’ antipathy to them triggered by the crackdown on rebates.
...
GSK's pediatric vaccines Synflorix wins international award at 2010 World Vaccine Congress
Synflorix, GlaxoSmithKline’s childhood pneumococcal vaccine, has received outstanding recognition by winning the Best Prophylactic Vaccine at the recent Vaccine Industry Excellence awards held at the 2010 World Vaccin...
Bukwang receives first royalty over Levovir
Bukwang said it has received a first royalty of US$31,000 from Eisai Co., for the marketing of Levovir capsule (clevudine) in the Philippines.
Levovir has been prescribed in such country after successful registrat...
Korea United launched novel formulation of aceclofenac tablets
Korea United has launched its novel formulation of aceclofenac tablets, a move that facilitates competition in the domestic analgesic and anti-inflammatory markets.
The drug, called Clanza CR tablet, is characteriz...
Lee Kyung-ho likely to be nominated as KPMA head
Lee Kyung-ho, an incumbent president of Inje University, is likely to be new president of the Korea Pharmaceutical Manufacturers Association.
The association said it will appoint a new president at the special meet...
53 companies to spend 540 billion won in R&D this year
A total of 53 local drug makers are expected to invest 540 billion won in research and development this year, according to the Korea Drug Research Association.
According to KDRA data, these companies will spend 312...
KFDA nods ACT based wound healing therapy
The Korea Food and Drug Administration said it has approved a new autologous cell therapy (ACT) developed by S. Biomedics, a local biopharmaceutical company.
Autologous material can be utilized as both a stand-alon...
Combo pills perks up firms’ profit
Influenced by the recent announcement of the drug agency announcement that 507 combination drugs should be subject to bioequivalence testing from this October, a growing number of companies are rushing to produce comb...
